Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
89.02 USD | -0.36% |
|
-3.19% | +8.74% |
Chart calendar Vaxcyte, Inc.
Upcoming events on Vaxcyte, Inc.
Past events on Vaxcyte, Inc.
2025-02-06 09:30 am | Guggenheim Securities SMID Cap Biotech Conference |
2024-12-03 12:30 pm | Evercore ISI HealthCONx Conference |
2024-11-20 05:00 pm | Jefferies London Healthcare Conference |
2024-11-12 01:30 pm | Guggenheim Securities Healthcare Innovation Conference |
2024-11-05 04:01 pm | Q3 2024 Earnings Release |
2024-09-18 10:20 am | Cantor Global Healthcare Conference |
2024-09-03 08:00 am | VAX-31 Phase 1/2 Topline Study Results Call |
2024-08-06 04:05 pm | Q2 2024 Earnings Release |
2024-06-06 11:30 am | Annual General Meeting |
2024-06-05 11:30 am | Jefferies Global Healthcare Conference |
2024-05-14 12:20 pm | BofA Securities Health Care Conference |
2024-05-08 04:05 pm | Q1 2024 Earnings Release |
2024-04-09 12:45 pm | Needham Healthcare Conference |
2024-03-12 | Jefferies Biotech on the Bay Summit |
2024-03-12 08:40 am | Leerink Partners Global Biopharma Conference |
2024-03-05 02:10 pm | TD Cowen Health Care Conference |
2024-02-27 04:30 pm | Q4 2023 Earnings Call |
2024-02-27 04:01 pm | Q4 2023 Earnings Release |
2024-02-08 10:00 am | Guggenheim Healthcare Talks Biotechnology Conference |
2023-11-28 08:20 am | Evercore ISI HealthCONx Conference |
Annual results
Fiscal Period | December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 25,0 |
EBITDA Million USD | Released Forecast Spread | -102 -98,0 -3.93% | -230 -211 -8.85% | -465 -324 -43.51% | -544 | -603 | -783 |
EBIT Million USD | Released Forecast Spread | -104 -103 -0.85% | -232 -216 -7.32% | -468 -386 -21.32% | -562 | -625 | -653 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -100 -101 1.04% | -223 -216 -3.44% | -402 -331 -21.65% | -499 | -556 | -499 |
Net income Million USD | Released Forecast Spread | -100 -100 0.04% | -223 -214 -4.19% | -402 -328 -22.55% | -490 | -559 | -541 |
EPS USD | Released Forecast Spread | -1,93 -1,89 -2.25% | -3,44 -3,33 -3.17% | -4,14 -3,49 -18.75% | -4,07 | -4,45 | -4,43 |
Announcement Date | 28/02/22 | 27/02/23 | 27/02/24 | - |
Quarterly results
Fiscal Period | September | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
EBITDA Million USD | Released Forecast Spread | -196 -54,6 -258.36% | -138 -112 -23.34% | -144 | |||||||||
EBIT Million USD | Released Forecast Spread | -71,2 -67,8 -5.03% | -87,1 -74,3 -17.34% | -113 -89,6 -26.1% | -197 -114 -71.88% | -114 -124 7.67% | -153 -121 -25.98% | -140 -150 6.8% | -156 | -162 | -166 | -169 | -163 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -60,5 -68,6 11.8% | -68,3 -70,5 3% | -92,7 -83,8 -10.62% | -181 -119 -51.64% | -95,0 -132 28.06% | -129 -109 -18.35% | -103 -144 28.54% | -172 | -157 | -159 | -161 | -163 |
Net income Million USD | Released Forecast Spread | -60,5 -65,3 7.44% | -68,3 -69,3 1.34% | -92,7 -81,0 -14.47% | -181 -106 -70.23% | -95,0 -123 22.46% | -129 -111 -15.43% | -103 -135 23.74% | -156 | -157 | -159 | -161 | -163 |
EPS USD | Released Forecast Spread | -0,70 -0,82 14.89% | -0,70 -0,75 6.04% | -0,91 -0,84 -8.66% | -1,82 -1,07 -69.7% | -0,85 -1,17 27.26% | -1,10 -0,98 -12.24% | -0,83 -1,14 26.87% | -1,21 | -1,25 | -1,25 | -1,30 | -1,35 |
Announcement Date | 08/05/23 | 08/08/23 | 06/11/23 | 27/02/24 | 08/05/24 | 06/08/24 | 05/11/24 | - | - | - | - | - |
2025-02-09 | ARROWHEAD PHARMACEUTICALS, INC.: Q1 2025 Earnings Release |
2025-02-10 04:01 pm | VERTEX PHARMACEUTICALS INCORPORATED: Q4 2024 Earnings Release |
2025-02-10 | ARVINAS, INC.: Q4 2024 Earnings Release |
2025-02-11 04:05 pm | EXELIXIS, INC.: Q4 2024 Earnings Release |
2025-02-12 07:30 am | ANAVEX LIFE SCIENCES CORP.: Q1 2025 Earnings Release |
2025-02-12 11:00 am | GENMAB A/S: Q4 2024 Earnings Release |
2025-02-12 04:01 pm | ASCENDIS PHARMA A/S: Q4 2024 Earnings Release |
2025-02-12 | AGIOS PHARMACEUTICALS, INC.: Q4 2024 Earnings Release |
2025-02-12 | ULTRAGENYX PHARMACEUTICAL INC.: Q4 2024 Earnings Release (Projected) |
2025-02-12 | PROTHENA CORPORATION PLC: Q4 2024 Earnings Release (Projected) |
Past sector events for Vaxcyte, Inc.
2025-02-06 04:00 pm | NEUROCRINE BIOSCIENCES, INC.: Q4 2024 Earnings Release |
2025-02-05 04:05 pm | VIKING THERAPEUTICS, INC.: Q4 2024 Earnings Release |
2025-02-05 05:42 am | PHARMAESSENTIA CORPORATION: January 2025 Sales and Revenue Release |
2025-02-04 06:30 am | REGENERON PHARMACEUTICALS, INC.: Q4 2024 Earnings Release |
2025-01-30 09:39 am | BIOCON LIMITED: Q3 2025 Earnings Release |
2025-01-28 04:00 pm | NURIX THERAPEUTICS, INC.: Q4 2024 Earnings Release |
2025-01-22 | ABL BIO INC.: Q4 2024 Earnings Release |
2025-01-10 02:53 am | LUMOSA THERAPEUTICS CO., LTD.: December 2024 Sales and Revenue Release |
2025-01-06 02:25 am | TAIMED BIOLOGICS INC.: December 2024 Sales and Revenue Release |
2025-01-04 10:28 pm | PHARMAESSENTIA CORPORATION: December 2024 Sales and Revenue Release |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- PCVX Stock
- Calendar Vaxcyte, Inc.